Europe Automated Cell Counting Market Size, Share & Industry Trends Analysis Report By Product, By Application (Cell Line development, Blood Analysis, Stem Cell Research, and Others), By End-use, By Country and Growth Forecast, 2023 - 2030
The Europe Automated Cell Counting Market would witness market growth of 11.8% CAGR during the forecast period (2023-2030).
A confluence of factors drives the exponential growth of the market. Research laboratories, biotechnology firms, pharmaceutical companies, academic institutions, and healthcare facilities increasingly rely on these instruments to meet the escalating demand for precise, high-throughput cell analysis. The constant need for accuracy in cellular quantification, viability assessment, and morphological characterization fuels the market's expansion. The evolving medical research and diagnostics landscape has propelled these instruments to the forefront.
Automated cell counting instruments are integral in various research fields, including immunology, oncology, stem cell research, drug discovery, and infectious diseases. These instruments are critical in analyzing blood cells and diagnosing haematological disorders in clinical diagnostics. The emergence of cell-based therapies and regenerative medicine drives the demand for precise and reliable cell-counting technologies. This is essential for quality control, assessing cell viability, and ensuring the effectiveness of cell-based therapies.
Healthcare expansion leads to increased availability of medical facilities, which drives the demand for advanced diagnostic tools like instruments for accurate and efficient diagnoses. Improved healthcare accessibility brings the need for efficient diagnostic technologies to various healthcare settings, increasing the adoption of these instruments in clinics, hospitals, and laboratories. Consequently, the expansion of the healthcare sector in the region and the increasing demand for medical technologies and equipment are factors propelling the expansion of the market.
The Germany market dominated the Europe Automated Cell Counting Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $539.1 million by 2030. The UK market is exhibiting a CAGR of 10.8% during (2023 - 2030). Additionally, The France market would experience a CAGR of 12.7% during (2023 - 2030).
Based on Product, the market is segmented into Consumables & Accessories, and Instruments (Image-based Cell Counters, Flow Cytometers, Electrical Impendence Coulter Counters). Based on Application, the market is segmented into Cell Line development, Blood Analysis, Stem Cell Research, and Others. Based on End-use, the market is segmented into Pharmaceutical & Biotechnology Companies, Hospitals & Diagnostic laboratories, Research & Academic Institutes, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Shanghai Ruiyu Biotechnology Co., Ltd. (Alit Biotech (Shanghai) Co., Ltd.), Thermo Fisher Scientific, Inc., Bio-Rad laboratories, Inc., F. Hoffmann-La Roche Ltd., Danaher Corporation, Olympus Corporation, Merck KGaA, Abbott Laboratories, Sysmex Corporation, and Agilent Technologies, Inc.
Scope of the Study
Market Segments covered in the Report:
By Product
- Consumables & Accessories
- Instruments
- Image-based Cell Counters
- Flow Cytometers
- Electrical Impendence Coulter Counters
- Cell Line development
- Blood Analysis
- Stem Cell Research
- Others
- Pharmaceutical & Biotechnology Companies
- Hospitals & Diagnostic laboratories
- Research & Academic Institutes
- Others
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
- Shanghai Ruiyu Biotechnology Co., Ltd. (Alit Biotech (Shanghai) Co., Ltd.)
- Thermo Fisher Scientific, Inc.
- Bio-Rad laboratories, Inc.
- F. Hoffmann-La Roche Ltd.
- Danaher Corporation
- Olympus Corporation
- Merck KGaA
- Abbott Laboratories
- Sysmex Corporation
- Agilent Technologies, Inc.
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
- Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 Europe Automated Cell Counting Market, by Product
- 1.4.2 Europe Automated Cell Counting Market, by Application
- 1.4.3 Europe Automated Cell Counting Market, by End-use
- 1.4.4 Europe Automated Cell Counting Market, by Country
- 1.5 Methodology for the research
- Chapter 2. Market at a Glance
- 2.1 Key Highlights
- Chapter 3. Market Overview
- 3.1 Introduction
- 3.1.1 Overview
- 3.1.1.1 Market Composition and Scenario
- 3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
- Chapter 4. Competition Analysis - Global
- 4.1 KBV Cardinal Matrix
- 4.2 Recent Industry Wide Strategic Developments
- 4.2.1 Partnerships, Collaborations and Agreements
- 4.2.2 Product Launches and Product Expansions
- 4.2.3 Acquisition and Mergers
- 4.2.4 Trials and Approvals
- 4.3 Top Winning Strategies
- 4.3.1 Key Leading Strategies: Percentage Distribution (2019-2023)
- 4.3.2 Key Strategic Move: (Product Launches and Product Expansions: 2019, Jun – 2022, Sep) Leading Players
- 4.4 Porter Five Forces Analysis
- Chapter 5. Europe Automated Cell Counting Market by Product
- 5.1 Europe Consumables & Accessories Market by Country
- 5.2 Europe Instruments Market by Country
- 5.3 Europe Automated Cell Counting Market by Instruments Type
- 5.3.1 Europe Image-based Cell Counters Market by Country
- 5.3.2 Europe Flow Cytometers Market by Country
- 5.3.3 Europe Electrical Impendence Coulter Counters Market by Country
- Chapter 6. Europe Automated Cell Counting Market by Application
- 6.1 Europe Cell Line development Market by Country
- 6.2 Europe Blood Analysis Market by Country
- 6.3 Europe Stem Cell Research Market by Country
- 6.4 Europe Others Market by Country
- Chapter 7. Europe Automated Cell Counting Market by End-use
- 7.1 Europe Pharmaceutical & Biotechnology Companies Market by Country
- 7.2 Europe Hospitals & Diagnostic laboratories Market by Country
- 7.3 Europe Research & Academic Institutes Market by Country
- 7.4 Europe Others Market by Country
- Chapter 8. Europe Automated Cell Counting Market by Country
- 8.1 Germany Automated Cell Counting Market
- 8.1.1 Germany Automated Cell Counting Market by Product
- 8.1.1.1 Germany Automated Cell Counting Market by Instruments Type
- 8.1.2 Germany Automated Cell Counting Market by Application
- 8.1.3 Germany Automated Cell Counting Market by End-use
- 8.2 UK Automated Cell Counting Market
- 8.2.1 UK Automated Cell Counting Market by Product
- 8.2.1.1 UK Automated Cell Counting Market by Instruments Type
- 8.2.2 UK Automated Cell Counting Market by Application
- 8.2.3 UK Automated Cell Counting Market by End-use
- 8.3 France Automated Cell Counting Market
- 8.3.1 France Automated Cell Counting Market by Product
- 8.3.1.1 France Automated Cell Counting Market by Instruments Type
- 8.3.2 France Automated Cell Counting Market by Application
- 8.3.3 France Automated Cell Counting Market by End-use
- 8.4 Russia Automated Cell Counting Market
- 8.4.1 Russia Automated Cell Counting Market by Product
- 8.4.1.1 Russia Automated Cell Counting Market by Instruments Type
- 8.4.2 Russia Automated Cell Counting Market by Application
- 8.4.3 Russia Automated Cell Counting Market by End-use
- 8.5 Spain Automated Cell Counting Market
- 8.5.1 Spain Automated Cell Counting Market by Product
- 8.5.1.1 Spain Automated Cell Counting Market by Instruments Type
- 8.5.2 Spain Automated Cell Counting Market by Application
- 8.5.3 Spain Automated Cell Counting Market by End-use
- 8.6 Italy Automated Cell Counting Market
- 8.6.1 Italy Automated Cell Counting Market by Product
- 8.6.1.1 Italy Automated Cell Counting Market by Instruments Type
- 8.6.2 Italy Automated Cell Counting Market by Application
- 8.6.3 Italy Automated Cell Counting Market by End-use
- 8.7 Rest of Europe Automated Cell Counting Market
- 8.7.1 Rest of Europe Automated Cell Counting Market by Product
- 8.7.1.1 Rest of Europe Automated Cell Counting Market by Instruments Type
- 8.7.2 Rest of Europe Automated Cell Counting Market by Application
- 8.7.3 Rest of Europe Automated Cell Counting Market by End-use
- Chapter 9. Company Profiles
- 9.1 Shanghai Ruiyu Biotechnology Co., Ltd. (Alit Biotech (Shanghai) Co., Ltd.)
- 9.1.1 Company Overview
- 9.2 Thermo Fisher Scientific, Inc.
- 9.2.1 Company Overview
- 9.2.2 Financial Analysis
- 9.2.3 Segmental and Regional Analysis
- 9.2.4 Research & Development Expenses
- 9.2.5 Recent strategies and developments:
- 9.2.5.1 Partnerships, Collaborations, and Agreements:
- 9.2.5.2 Product Launches and Product Expansions:
- 9.2.5.3 Acquisition and Mergers:
- 9.2.6 SWOT Analysis
- 9.3 Bio-Rad laboratories, Inc.
- 9.3.1 Company Overview
- 9.3.2 Financial Analysis
- 9.3.3 Segmental and Regional Analysis
- 9.3.4 Research & Development Expenses
- 9.3.5 SWOT Analysis
- 9.4 F. Hoffmann-La Roche Ltd.
- 9.4.1 Company Overview
- 9.4.2 Financial Analysis
- 9.4.3 Segmental and Regional Analysis
- 9.4.4 Research & Development Expense
- 9.4.5 Recent strategies and developments:
- 9.4.5.1 Partnerships, Collaborations, and Agreements:
- 9.4.5.2 Product Launches and Product Expansions:
- 9.4.6 SWOT Analysis
- 9.5 Danaher Corporation
- 9.5.1 Company Overview
- 9.5.2 Financial Analysis
- 9.5.3 Segmental and Regional Analysis
- 9.5.4 Research & Development Expense
- 9.5.5 SWOT Analysis
- 9.6 Olympus Corporation
- 9.6.1 Company Overview
- 9.6.2 Financial Analysis
- 9.6.3 Segmental and Regional Analysis
- 9.6.4 Recent strategies and developments:
- 9.6.4.1 Product Launches and Product Expansions:
- 9.6.5 SWOT Analysis
- 9.7 Merck KGaA
- 9.7.1 Company Overview
- 9.7.2 Financial Analysis
- 9.7.3 Segmental and Regional Analysis
- 9.7.4 Research & Development Expense
- 9.7.5 Recent strategies and developments:
- 9.7.5.1 Product Launches and Product Expansions:
- 9.7.6 SWOT Analysis
- 9.8 Abbott Laboratories
- 9.8.1 Company Overview
- 9.8.2 Financial Analysis
- 9.8.3 Segmental and Regional Analysis
- 9.8.4 Research & Development Expense
- 9.8.5 Recent strategies and developments:
- 9.8.5.1 Trials and Approvals:
- 9.8.6 SWOT Analysis
- 9.9 Sysmex Corporation
- 9.9.1 Company Overview
- 9.9.2 Financial Analysis
- 9.9.3 Regional Analysis
- 9.9.4 Research & Development Expense
- 9.9.5 Recent strategies and developments:
- 9.9.5.1 Partnerships, Collaborations, and Agreements:
- 9.9.5.2 Product Launches and Product Expansions:
- 9.9.6 SWOT Analysis
- 9.10. Agilent Technologies, Inc.
- 9.10.1 Company Overview
- 9.10.2 Financial Analysis
- 9.10.3 Segmental and Regional Analysis
- 9.10.4 Research & Development Expense
- 9.10.5 Recent strategies and developments:
- 9.10.5.1 Product Launches and Product Expansions:
- 9.10.5.2 Acquisition and Mergers:
- 9.10.6 SWOT Analysis
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook